NDC 67457-0847-44

Trastuzumab-dkst (Ogivri) 420 mg IV infusion drug at Warsaw Health System LLC

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-sonnet-5-5
Provider: anthropic
API: message_batches
Reasoning effort: model default
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

67457-0847-44 - trastuzumab dkst 420 mg Powder

Warsaw, IN

See all hospitals reporting NDC 67457-0847-44 →

SharePost on X LinkedIn Download image

Pricing by billing methodology

Price type

How this price compares nationally

Warsaw Health System LLC’s median price of $254 is 91% below the median hospital's median price ($2.7k), higher than 42% of the 156 hospitals reporting NDC 67457-0847-44. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Last updated: Apr 1, 2026

Compare to other hospitals

See Trastuzumab-dkst (Ogivri) 420 mg IV infusion drug pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.